South Rampart Pharma is a clinical-stage life science company focusing on overcoming current pain medicines risks.
South Rampart Pharma has raised $8.0M in total funding. The most recent round was Series A. The last funding was announced in May 2025.
South Rampart Pharma's investors include National Institutes of Health, Ochsner Health System, Gulf South Angels.
South Rampart Pharma is headquartered in New Orleans, United States.
South Rampart Pharma is a clinical-stage life science company focusing on overcoming current pain medicines risks.
South Rampart Pharma is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"South Rampart Pharma — Funding & Investors." VCBacked, May 21, 2025, https://www.vcbacked.co/company/south-rampart-pharma. Accessed July 20, 2026.
VCBacked. (2025). South Rampart Pharma — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/south-rampart-pharma
{{cite web |title=South Rampart Pharma — Funding & Investors |url=https://www.vcbacked.co/company/south-rampart-pharma |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated